11.8 C
New York
Tuesday, November 24, 2020
Home Stories Targets for COVID-19 vaccine identified by scientists

Targets for COVID-19 vaccine identified by scientists

Scientists have identified regions of the SARS-CoV-2 virus that causes COVID-19 to target with a vaccine, by harnessing tools used for the development of cancer immunotherapies.

The researchers at Children’s Hospital of Philadelphia (CHOP) in the US employed the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the novel coronavirus.

Using this strategy, the researchers believe a resulting vaccine would provide protection across the human population and drive a long-term immune response.

“In many ways, cancer behaves like a virus, so our team decided to use the tools we developed to identify unique aspects of childhood cancers that can be targeted with immunotherapies and apply those same tools to identify the right protein sequences to target in SARS-CoV-2,” said John M Maris, a pediatric oncologist at CHOP, and a professor at the University of Pennsylvania.

“We think our approach provides a roadmap for a vaccine that would be both safe and effective and could be produced at scale,” said Maris, senior author of the research published in the journal Cell Reports Medicine.

The COVID-19 pandemic has led to an urgent need for the development of a safe and effective vaccine against SARS-CoV-2, the virus that causes the COVID-19 disease, the researchers said.

An optimally designed vaccine maximises a long-lasting immune response, while minimising adverse reactions, autoimmunity, or disease exacerbation, they said.

To increase the likelihood that a vaccine is both safe and effective, the research team prioritised parameters in identifying regions of the virus to target.

The researchers looked for regions that would stimulate a memory T-cell response that, when paired with the right B cells, would drive memory B cell formation and provide lasting immunity and do so across the majority of human genomes.

They targeted regions of SARS-CoV-2 that are present across multiple related coronaviruses, as well as new mutations that increase infectivity, while also ensuring that those regions were as dissimilar as possible from sequences naturally occurring in humans to maximize safety.

The researchers propose a list of 65 peptide sequences that, when targeted, offer the greatest probability of providing population-scale immunity.

The team will now test various combinations of a dozen or so of these sequences in mouse models to assess their safety and effectiveness.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

- Advertisment -

Most Popular

UMI Blockchain Ecosystem: Instant Transfers, Smart Contracts, And Profitable Staking

Thus far, the number of issued cryptocurrencies and digital tokens has exceeded 7 thousand, and in this ocean of crypto Projects, it is difficult...

ALERT! Indian Government Bans 43 Mobile Apps! Here’s The Complete List

The MEITY (Ministry of Electronics and Information Technology) issued an order on November 24 to prohibit access to 43 mobile applications in India. The order...

Cyber Threats Could Risk Your Data, Fund managers. Be prepared

It’s a busy Monday at the office. Amid frantic meetings, calls, and discussions, you notice an intriguing email from a company and decide to...

Global Airlines Are Developing Mobile Applications That Will Help Travelers Demonstrate Their Coronavirus-Free Status

IATA, the Global airline lobby, is developing a mobile application that will help travelers confirm their coronavirus-free status and promote the launch of the...

Recent Comments

%d bloggers like this: